Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2218]

ESMO 2014: Little benefit for gefitinib-resistant lung cancer when continuing the drug with chemo

ESMO 2014: Little benefit for gefitinib-resistant lung cancer when continuing the drug with chemo

ESMO 2014: Access to breast cancer drug lacking in Eastern Europe

ESMO 2014: Access to breast cancer drug lacking in Eastern Europe

ESMO 2014: Canada and Europe sometimes years slower than USA in approving cancer drugs

ESMO 2014: Canada and Europe sometimes years slower than USA in approving cancer drugs

ESMO 2014: More than 70% of young oncologists in Europe suffer symptoms of burnout

ESMO 2014: More than 70% of young oncologists in Europe suffer symptoms of burnout

EAPM takes its messages to the European Society Medical Oncology Congress

EAPM takes its messages to the European Society Medical Oncology Congress

Healthcare professionals reunite at ESMO 2014 to support multidisciplinary care for head and neck cancer patients across Europe

Healthcare professionals reunite at ESMO 2014 to support multidisciplinary care for head and neck cancer patients...

Ramucirumab gets go ahead from European Medicines Agency

Ramucirumab gets go ahead from European Medicines Agency

Less costly to screen for and treat early-stage lung than to treat late-stage lung cancer

Less costly to screen for and treat early-stage lung than to treat late-stage lung cancer

New European roadmap established to tackle paediatric cancer

New European roadmap established to tackle paediatric cancer

Countries with high stomach cancer burden need to do more to prevent the disease

Countries with high stomach cancer burden need to do more to prevent the disease

More from ecancer